Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rachel C Miller"'
Publikováno v:
CHI Conference on Human Factors in Computing Systems Extended Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6d7fb4826b94845369f3bb3c9bf3d26
https://doi.org/10.1145/3491101.3514486
https://doi.org/10.1145/3491101.3514486
Autor:
James Cloud, Holly Chitwood, Aman Chauhan, Reema Anil Patel, Rachel C. Miller, Lowell Anthony, Katherine Mitchell, Fariha Siddiqui, Zachary Tarter, Laura Luque
Publikováno v:
Journal of Clinical Oncology. 38:e24107-e24107
e24107 Background: Gastrointestinal toxicity is a common side effect of cancer therapy. Pre-clinical studies using a proprietary mixture of amino acids, demonstrated a reduction in mucositis and gastrointestinal toxicity following irradiation via tig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6feef747445d66cb8732fd68331d20f2
https://doi.org/10.1200/jco.2020.38.15_suppl.e24107
https://doi.org/10.1200/jco.2020.38.15_suppl.e24107
Publikováno v:
Journal of Clinical Oncology. 38:614-614
614 Background: Diarrhea is a common quality of life limiting symptom seen in neuroendocrine tumor patient. Diarrhea in these patients could be due to excessive serotonin production, secondary to post-operative short gut syndrome, steatorrhea from so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9cd6faf07723b066ce00ec3ae7c3082
https://doi.org/10.1200/jco.2020.38.4_suppl.614
https://doi.org/10.1200/jco.2020.38.4_suppl.614
Autor:
Heidi L. Weiss, Rachel C. Miller, Zackary Tarter, Lowell Anthony, Qian Yu, Aman Chauhan, Laura Luque, Fariha Siddiqui
Publikováno v:
Journal of Clinical Oncology. 36:218-218
218 Background: Gastroenteropancreatic neuroendocrine tumor (GEPNET) incidence has risen 6-fold over past 3 decades. North American Neuroendocrine Tumor Society estimates that over 100,000 GEPNET patients are currently living in the United States. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e04cdd50d8edec1d93ab5d61a77a736e
https://doi.org/10.1200/jco.2018.36.34_suppl.218
https://doi.org/10.1200/jco.2018.36.34_suppl.218
Publikováno v:
Journal of Clinical Oncology. 36:e22217-e22217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::befc074c34a0718e1481fda6f32cccd1
https://doi.org/10.1200/jco.2018.36.15_suppl.e22217
https://doi.org/10.1200/jco.2018.36.15_suppl.e22217
Publikováno v:
Journal of Clinical Oncology. 36:509-509
509 Background: Based on SEER database, gastroenteropancreatic neuroendocrine tumor incidence has increased 6 fold from 1 in 100,000 cases to about 6 in 100,000 cases over past 3 decades. North American Neuroendocrine Tumor Society estimates that ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07fdcf6750ef1c4a3373e3fdeda244e5
https://doi.org/10.1200/jco.2018.36.4_suppl.509
https://doi.org/10.1200/jco.2018.36.4_suppl.509